Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of THC and CBD on Psychosis Model in Healthy Volunteers
NCT02487381Phase 1Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Apr 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol and dronabinol in psychosis (4 arms), sponsored by Central Institute of Mental Health. Primary endpoint: Positive and Negative Syndrome Scale Total Score at 4 hours. Started Apr 2015; status: completed.
02
Drugs
cannabidioldronabinol
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT02487381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487381.